Does Cocoa Flavanol Cognition Randomized Trial work?

The current Migaku evidence database contains 2 reusable source documents for Cocoa Flavanol Cognition Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - 1 2 3 3 3 4 5 6 The characteristics of dementia syndrome are cognitive dysfunction, including memory loss, reduced executive functions, language impairment, and affected performance in daily life activities []. [Sbai Oualid (2026); evidence level 4] - Notably, about 70% of older people are living in low–middle income countries [], representing a significant economic weight associated with medical costs for health systems []. [Sbai Oualid (2026); evidence level 4] - In addition, it is necessary to unveil the risk factors promoting dementia in order to develop preventive strategies. [Sbai Oualid (2026); evidence level 4] - Dementia affects approximately 55 million individuals worldwide, and its prevalence is expected to rise up to 131.5 million by 2050, representing a major global health challenge [,]. [Sbai Oualid (2026); evidence level 4] - Alzheimer's disease (AD) is a major global neurodegenerative disorder associated with high morbidity and mortality, yet current treatments remain largely symptomatic and ineffective in halting neurodegeneration. [Zainuddin MS (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.